The 4 IAS-OSLA Course on “Lipid Metabolism and ...The 4th IAS-OSLA Course on “Lipid Metabolism...
1
The 4 th IAS-OSLA Course on “Lipid Metabolism and Cardiovascular Risk” Muscat, Oman, February 16-19, 2018 DAY 1 Friday, February 16 Time (Day 2) DAY 2 Saturday, February 17 DAY 3 Sunday, February 18 DAY 4 Monday, February 19 7.30 – 8.30 BREAKFAST BREAKFAST BREAKFAST 8.30 – 9.15 Introductions Pre-Course Test LDL, HDL and CVD: Epidemiology and Clinical Trials Philip Barter (Australia) Genetic Dyslipidaemia and CVD Fahad Al-Zadjali (Oman) 9.15 – 10.00 Lipid/Lipoprotein Structure and Metabolism (Overview) Philip Barter (Australia) Agents to Reduce LDL (and Future Developments) Raul Santos (Brazil) Update on Lipid Guidelines Khalid Al-Waili (Oman) 10:00 – 10.45 Metabolism and Atherogenic Properties of LDL Manfredi Rizzo (Italy) Metabolism, Atherogenic Properties and Agents to reduce Triglyceride-Rich Lipoproteins, Manfredi Rizzo (Italy) Diabetes, Metabolic Syndrome and CVD Noor Al-Busaidi (Oman) 10.45-11.15 COFFEE BREAK COFFEE BREAK COFFEE BREAK 11.15 – 12.00 Metabolism and Protective Properties of HDL Philip Barter (Australia) Agents to Raise HDL Philip Barter (Australia) Statin Tolerability: Overcoming the Treatment Gap Zuhier Ahmed Awan (KSA) 12.00 – 12.45 PCSK9 and its Role in LDL Receptor Regulation Gilles Lambert (France) Metabolism, Atherogenic Properties and Agents to Reduce Lipoprotein(a) Gilles Lambert (France) Management of dyslipidaemia in special populations Dimitri Mikhailidis (UK) 12.45 – 13.30 CVD risk assessment using risk scores In primary and secondary prevention Raul Santos (Brazil) Effect of diet on dyslipidaemia and CVD Khalid Al-Rasadi (Oman) Participant’s Debate Session: The use of statin alone vs adding non-statin in the management of dyslipidemia (All Faculty) Participant’s Debate Session: The use of LDL-C alone vs adding non-HDL-C in the management of dyslipidemia (All Faculty) 13.30 – 14.30 LUNCH LUNCH LUNCH 14.30 – 17.30 WORKSHOP 1 Management of Patients with Familial Hypercholesterolemia Zuhier Awan (KSA)/ Raul Santos (Brazil) Khalid Al-Waili (Oman)/ Dimitri Mikhailidis (UK) Manal Al-Kindi (Oman)/ Gilles Lambert (France) WORKSHOP 2 Management of Patients with Complex Lipid Cases Khamis Al-Hashmi (Oman)/ Raul Santos (Brazil) Noor Al-Busaidi (Oman)/ Dimitri Mikhailidis (UK) Zuhier Awan (KSA) / Gilles Lambert (France) WORKSHOP 3 Management of Lipid Disorders in Special Populations Fahad Al-Zadjali (Oman) / Manfredi Rizzo (Italy) Dimitri Mikhailidis (UK)/ Manal Al-Kindi (Oman) Khalid Al-Waili (Oman)/ Mutaz Alkhnifsawi (Iraq) Faculty Meeting 16.30 – 17.30 17.30 – 18.30 Post-Course Test Evaluation & Discussion WELCOME DINNER 19.30 – 22.00 19:00 – 21:00 DINNER DINNER FAREWELL RECEPTION 19.00 – 21.30
Transcript of The 4 IAS-OSLA Course on “Lipid Metabolism and ...The 4th IAS-OSLA Course on “Lipid Metabolism...
The4thIAS-OSLACourseon“LipidMetabolismandCardiovascularRisk”Muscat,Oman,February16-19,2018
DAY1Friday,
February16Time(Day2) DAY2
Saturday,February17DAY3
Sunday,February18DAY4
Monday,February19
7.30–8.30 BREAKFAST BREAKFAST BREAKFAST
8.30–9.15 IntroductionsPre-CourseTest
LDL,HDLandCVD:EpidemiologyandClinicalTrials
PhilipBarter(Australia)
GeneticDyslipidaemiaandCVDFahadAl-Zadjali(Oman)
9.15–10.00Lipid/LipoproteinStructureandMetabolism
(Overview)PhilipBarter(Australia)
AgentstoReduceLDL(andFutureDevelopments)
RaulSantos(Brazil)
UpdateonLipidGuidelinesKhalidAl-Waili(Oman)
10:00–10.45MetabolismandAtherogenic
PropertiesofLDLManfrediRizzo(Italy)
Metabolism,AtherogenicPropertiesandAgentstoreduceTriglyceride-RichLipoproteins,
ManfrediRizzo(Italy)
Diabetes,MetabolicSyndromeandCVDNoorAl-Busaidi(Oman)
10.45-11.15 COFFEEBREAK COFFEEBREAK COFFEEBREAK
11.15–12.00 MetabolismandProtectivePropertiesofHDLPhilipBarter(Australia)
AgentstoRaiseHDLPhilipBarter(Australia)
StatinTolerability:OvercomingtheTreatmentGapZuhierAhmedAwan(KSA)
12.00–12.45 PCSK9anditsRoleinLDLReceptorRegulationGillesLambert(France)
Metabolism,AtherogenicPropertiesandAgentstoReduceLipoprotein(a)GillesLambert(France)
ManagementofdyslipidaemiainspecialpopulationsDimitriMikhailidis(UK)
12.45–13.30CVDriskassessmentusingriskscoresInprimaryandsecondaryprevention
RaulSantos(Brazil)
EffectofdietondyslipidaemiaandCVDKhalidAl-Rasadi(Oman)
Participant’sDebateSession:Theuseofstatinalonevsaddingnon-statininthemanagementof
dyslipidemia(AllFaculty)
Participant’sDebateSession:TheuseofLDL-Calonevsaddingnon-HDL-Cinthemanagementof
dyslipidemia(AllFaculty)
13.30–14.30 LUNCH LUNCH LUNCH
14.30–17.30
WORKSHOP1ManagementofPatientswithFamilial
HypercholesterolemiaZuhierAwan(KSA)/RaulSantos(Brazil)
KhalidAl-Waili(Oman)/DimitriMikhailidis(UK)ManalAl-Kindi(Oman)/GillesLambert
(France)
WORKSHOP2
ManagementofPatientswithComplexLipidCases
KhamisAl-Hashmi(Oman)/RaulSantos(Brazil)NoorAl-Busaidi(Oman)/DimitriMikhailidis(UK)ZuhierAwan(KSA)/GillesLambert(France)
WORKSHOP3ManagementofLipidDisordersinSpecialPopulations
FahadAl-Zadjali(Oman)/ManfrediRizzo(Italy)DimitriMikhailidis(UK)/ManalAl-Kindi(Oman)KhalidAl-Waili(Oman)/MutazAlkhnifsawi(Iraq)
FacultyMeeting
16.30–17.3017.30–18.30
Post-CourseTest
Evaluation&Discussion
WELCOMEDINNER
19.30–22.0019:00–21:00 DINNER DINNER FAREWELLRECEPTION
19.00–21.30
